Targeting Microbiota 2024: Confirmed Speakers

Gut Microbiome, Obesity and Diabetes
Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan

Human Microbiome Myths and Misconceptions
Alan Walker, University of Aberdeen, United Kindgom

Probiotics & Health: How to Select the Right Strain?
Andreas Schwiertz, Institute of Microecology, Germany

Gut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed
José Manuel Fernández-Real, Universitat de Girona, Spain

Targeting Small Intestinal Microbiota: Impact on Metabolism
Pascale Vonaesch, Lausanne University, Switzerland

Microbiota-Derived Extracellular Vesicles: Bridging Mother and Fetus
Justus Reunanen, University of Oulu, Finland

Microbial Phenotypes in Obesity: Implications for Precision Nutrition
Ellen Blaak, Maastricht University, Netherlands

Phage Therapy & Microbiome Medicine: Emerging Applications and Challenges
Martin Lössner, ETH Zurich, Switzerland

Sophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease
Koen Venema, Editor-in-chief of Beneficial Microbes, Netherlands

Targeting the Gut-Brain Axis: The Role of Microbiota Manipulation
Rochellys Diaz Heijtz, Karolinska Institutet, Sweden

Gut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience
Patrick C. H. Hsieh, Academia Sinica, Tawian

The Oral-Placental Microbiome Axis in Preterm Birth
Souhaila Al Khodor, Sidra Medicine, Qatar

Gut Microbiome Signatures in Irritable Bowel Syndrome
Simone Domenico Guglielmetti, Università degli Studi di Milano-Bicocca, Italy

From (Meta)genomes and Microbiomes and Back - Identification, Production and Application of Bacteriocins
Christian Riedel, University of Ulm, Germany